Doxorubicin

folate hydrolase 1 ; Homo sapiens







22 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 34977528 Cascade targeting codelivery of ingenol-3-angelate and doxorubicin for enhancing cancer chemoimmunotherapy through synergistic effects in prostate cancer. 2022 Jan 1
2 35223775 PSMA-Targeted Supramolecular Nanoparticles Prepared From Cucurbit[8]uril-Based Ternary Host-Guest Recognition for Prostate Cancer Therapy. 2022 4
3 34121558 Combination prostate cancer therapy: Prostate-specific membranes antigen targeted, pH-sensitive nanoparticles loaded with doxorubicin and tanshinone. 2021 Dec 2
4 34274531 Dually targeted bioinspired nanovesicle delays advanced prostate cancer tumour growth in vivo. 2021 Oct 15 1
5 32191376 DNA Origami-Enabled Engineering of Ligand-Drug Conjugates for Targeted Drug Delivery. 2020 Apr 1
6 30904185 Synthesis and biological evaluation of Doxorubicin-containing conjugate targeting PSMA. 2019 May 15 3
7 31056242 Corrigendum to 'Synthesis and biological evaluation of Doxorubicin-containing conjugate targeting PSMA' [Bioor. Med. Chem. Lett. 29/10 (2019) 1246-1255]. 2019 Jul 1 1
8 27966863 MT1-MMP Responsive Doxorubicin Conjugated Poly(lactic-co-glycolic Acid)/Poly(styrene-alt-maleic Anhydride) Core/Shell Microparticles for Intrahepatic Arterial Chemotherapy of Hepatic Cancer. 2017 Jan 11 10
9 28711780 Localised delivery of doxorubicin to prostate cancer cells through a PSMA-targeted hyperbranched polymer theranostic. 2017 Oct 2
10 28744329 PSMA-Targeted Theranostic Nanocarrier for Prostate Cancer. 2017 1
11 26985893 A RNA-DNA Hybrid Aptamer for Nanoparticle-Based Prostate Tumor Targeted Drug Delivery. 2016 Mar 14 1
12 27219717 Site-Directed Conjugation of Antibodies to Apoferritin Nanocarrier for Targeted Drug Delivery to Prostate Cancer Cells. 2016 Jun 15 4
13 24955779 Poly(styrene-alt-maleic anhydride)-based diblock copolymer micelles exhibit versatile hydrophobic drug loading, drug-dependent release, and internalization by multidrug resistant ovarian cancer cells. 2014 Jul 14 1
14 25450401 RNA aptamer-conjugated liposome as an efficient anticancer drug delivery vehicle targeting cancer cells in vivo. 2014 Dec 28 1
15 23582862 Aptamer-conjugated and doxorubicin-loaded unimolecular micelles for targeted therapy of prostate cancer. 2013 Jul 1
16 23860551 Dimeric DNA Aptamer Complexes for High-capacity-targeted Drug Delivery Using pH-sensitive Covalent Linkages. 2013 Jul 16 4
17 21147500 Dual-aptamer-based delivery vehicle of doxorubicin to both PSMA (+) and PSMA (-) prostate cancers. 2011 Mar 4
18 20550178 A drug-loaded aptamer-gold nanoparticle bioconjugate for combined CT imaging and therapy of prostate cancer. 2010 Jul 27 1
19 18686131 Prostate cancer-specific monoclonal antibody 5D4 significantly enhances the cytotoxicity of doxorubicin-loaded liposomes against target cells in vitro. 2008 Aug 1
20 16892363 Design and synthesis of a PSMA inhibitor-doxorubicin conjugate for targeted prostate cancer therapy. 2006 Mar 1
21 20641322 Quantum dot-A10 RNA aptamer-doxorubicin conjugate 2004 5
22 20641568 Thermally cross-linked superparamagnetic iron oxide nanoparticle-A10 RNA aptamer-doxorubicin conjugate 2004 6